Talawar bets bispecific approach can shake up eczema market - STAT News
An AI skeptic now wants to use it to optimize biotech economics. Investor Clive Meanwell recently watched as Pfizer and Novo Nordisk frenetically ...
Read the original at STAT News ↗
- Topics
- Markets & Investment
- Tracked via
- “AI skeptic”